Skip to main content

Peer Review reports

From: A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

Original Submission
8 Mar 2007 Submitted Original manuscript
28 Jun 2007 Author responded Author comments - Mitchell Gross
13 Apr 2007 Reviewed Reviewer Report - Jonathan Rosenberg
12 Jun 2007 Reviewed Reviewer Report - William Berry
15 Jun 2007 Reviewed Reviewer Report - Damian Laber
Resubmission - Version 2
28 Jun 2007 Submitted Manuscript version 2
24 Jul 2007 Author responded Author comments - Mitchell Gross
12 Jul 2007 Reviewed Reviewer Report - Jonathan Rosenberg
12 Jul 2007 Reviewed Reviewer Report - Damian Laber
Resubmission - Version 3
24 Jul 2007 Submitted Manuscript version 3
Publishing
27 Jul 2007 Editorially accepted
27 Jul 2007 Article published 10.1186/1471-2407-7-142

You can find further information about peer review here.

Back to article page
\